Medtech BioCam to enter NewConnect
20:26
BioCam aims to debut on NewConnect in mid-2024 as part of its financing strategy to support the development and commercialization of its AI-supported endoscopic capsule technology. The technology, set for commercial debut in Q4 2024, targets both human and veterinary medicine.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
